|
There are 2 general types of surgery used for exocrine
pancreatic cancer:
- Potentially
curative surgery is used when imaging tests suggest that
it is possible to remove all the cancer.
- Palliative
surgery may be done if imaging tests show that the tumor
is too widespread to be completely removed. This is done to relieve
symptoms or to prevent certain complications liked a blocked bile duct
or intestinal tract.
Several studies have shown that removing only part of the
cancer does not help patients to live longer. Pancreatic cancer surgery
is one of the most difficult operations a surgeon can do. It is also
one of hardest for patients to undergo. There may be complications and
it may take several weeks for patients to recover. Patients need to
weigh the potential benefits and risks of such surgery carefully.
Potentially curative surgery
Most curative surgery is designed to treat cancers at the head
of the pancreas. Because these cancers are near the bile duct, some of
them cause jaundice and are found early enough to be removed. Surgeries
for other parts of the pancreas are mentioned below, but these are only
done when complete removal of the cancer will be possible.
There are 3 procedures used to remove tumors of the pancreas:
Pancreaticoduodenectomy
(Whipple procedure): This is the most common operation to
remove a cancer of the exocrine pancreas. It involves removing the head
of pancreas and sometimes the body of the pancreas as well. Part of the
stomach, small intestine, and lymph nodes near the pancreas are also
removed. The gallbladder and part of the common bile duct are removed
and the remaining bile duct is attached to the small intestine so that
bile from the liver can continue to enter the small intestine.
This is a complex operation that requires much skill and
experience. It carries a relatively high risk of complications that may
even be fatal. When the operation is done in small hospitals or by
doctors with less experience, more than 15% of patients may die as a
result of surgical complications. In contrast, when this operation is
performed in cancer centers by surgeons experienced in the procedure,
less than 5% of patients die as a direct result of complications from
surgery. Still, even in the best of hands, many patients suffer
complications from the surgery. These can include:
- leaking from the various connections that the surgeon has
to make
- infections
- bleeding
- trouble with the stomach emptying itself after eating
For patients to have the best outcomes, they should be treated
by a surgeon who does many of these operations. In general, people
having this type of surgery do better when it is performed at a
hospital that does at least 20 pancreas surgeries per year.
At the time of diagnosis, only about 10% of cancers of the
pancreas appear to be contained entirely within the pancreas. Only
about half of these turn out to be truly resectable once the surgery is
started. Still, even if all the visible tumor is removed at the time of
surgery, some cancer cells may have already spread to other parts of
the body. These cells may eventually grow into new tumors and cause
many problems -- even death. Among patients who have surgery with the
intent of completely removing a cancer of the exocrine pancreas, the
5-year survival rate is about 20%.
Distal
pancreatectomy: This operation removes only the tail of
the pancreas or the tail and a portion of the body of the pancreas. The
spleen is usually removed as well. This operation is used more often
with islet cell tumors found in the tail and body of the pancreas. It
is seldom used to treat cancers of the exocrine pancreas because these
tumors have usually already spread by the time they are found.
Total
pancreatectomy: This operation was once used for tumors in
the body or head of the pancreas. It removes the entire pancreas and
the spleen. It is now seldom used to treat exocrine cancers of the
pancreas because there doesn't seem to be any advantage to removing the
whole pancreas. It is possible to live without a pancreas. But when the
entire pancreas is removed, people are left without any islet cells,
the cells that make insulin. These people develop diabetes, which can
be hard to manage because they become totally dependent on insulin.
Palliative surgery
If the cancer has spread too far to be completely removed, any
surgery being considered would be palliative (intended to relieve or
prevent symptoms). Because pancreatic cancer can progress quickly, most
doctors do not advise surgery for palliation. However, sometimes
surgery may begin with the hope it will cure the patient, but the
surgeon discovers this is not possible. In this case, the surgeon may
continue the operation as a palliative procedure to relieve or prevent
symptoms.
Cancers growing in the head of the pancreas can block the
common bile duct as it passes through this part of the pancreas. This
may cause pain and digestive problems because the bile can't get into
the intestine. The bile chemicals will build up in the body. There are
2 options for relieving bile duct blockage.
Surgery can be done to reroute the flow of bile from the
common bile duct directly into the small intestine, bypassing the
pancreas. This requires a large incision in the abdomen, and it may
take weeks to completely recover. One advantage is that during this
procedure, the surgeon may be able to cut the nerves leading to the
pancreas or inject them with alcohol. This may reduce or get rid of any
pain that may be caused by the cancer. Sometimes, the stomach
connection to the duodenum (the first part of the small intestine) is
rerouted at this time as well. Often, late in the course of pancreatic
cancer, the duodenum becomes blocked by cancer, which can cause pain
and vomiting that requires surgery. Bypassing the duodenum before this
happens can help avoid a second operation.
A second approach to relieving a blocked bile duct does not
involve surgery. Instead, a stent (small tube) is placed in the duct to
keep it open. This is usually done through an endoscope (a long,
flexible tube) while the patient is sedated. The doctor passes the
endoscope down the patient's throat and all the way into the small
intestine. The doctor can then insert the stent into the bile duct
through the endoscope. The stent, which is usually made of metal, helps
keep the bile duct open and resists compression from the surrounding
cancer. After several months, the stent may become clogged and may need
to be cleared. Larger stents are also available to keep the small
intestine open if it is in danger of being blocked.
In general, of the use of endoscopically-placed stents has
replaced surgery to relieve bile duct obstruction. Stents can also be
placed before surgery to relieve jaundice before the pancreas is
removed.
Surgery to treat pancreatic endocrine tumors
and cancers
In addition to the procedures described above, some less
extensive procedures may be used to remove pancreatic endocrine tumors.
Often laparoscopy is done first to better locate the tumor and see how
far it has spread.
Sometimes with small tumors, just the tumor itself is removed.
This is called enucleation. This operation may be done using a
laparoscope, so that only a few small incisions are needed. This
operation may be all that is needed to treat an insulinoma, since this
type of tumor is often benign.
Small (tumors 2 inches or less) gastrinomas may also be
treated with enucleation, but the duodenum (the first part of the small
intestine) is removed as well. Larger gastrinomas may require a
pancreaticduodenectomy or a distal pancreatectomy, depending on the
location of the tumor.
The lymph nodes around the pancreas are removed in some cases
as well. This is known as a peripancreatic lymph node dissection. The
lymph nodes are removed so that they can be checked for signs of tumor
spread.
Surgery may be used to remove metastases if a pancreatic
endocrine tumor has spread. This can be used with spread to the liver
(the most common site of spread) and the lungs. Removing metastases can
improve symptoms and prolong life in patients with pancreatic endocrine
tumors. In rare cases, liver transplantation may be used to treat
pancreatic endocrine tumors that have spread to the liver.
Last Medical Review: 10/13/2009 Last Revised: 10/13/2009
|